Overview
Availability
- Dr Jake O'Donnell is:
- Available for supervision
Qualifications
- Bachelor (Honours), The University of Queensland
- Doctor of Philosophy, The University of Queensland
- Masters (Coursework) of Business Administration, Griffith University
Research interests
-
Monoclonal Antibody Development
We have developed a pipeline for rapid flow cytometry and cell-sorting-based development of either mouse or human monoclonal antibodies with potential uses as research tools or therapies.
-
Human T-lymphotropic virus 1 (HTLV-1) and Adult T cell Leukemia/Lymphoma (ATLL)
We have interests in the development of therapies for treatment of HTLV-1 and ATLL using basic research principles and structural biological approaches.
-
Understanding the impacts of vaccine adjuvants on immune responses
We have interests in characterising the impacts that specific antigen/adjuvant pairings have in vaccine development, and how this understanding can guide adjuvant selection in vaccine development
-
The structural basis for anti-retroviral efficacy for novel indications
We have interest in understanding the applicability and potential efficacy of existing and novel anti-retroviral therapies for treatment of different retroviral infections. Our current focuses are on HTLV-1 and Koala Retrovirus.
-
Immunology of koalas, retrovirology, and disease susceptibility
We have a strong interest in understanding the impacts of koala retrovirus (KoRV) on koala immunology and disease susceptibility.
Works
Search Professor Jake O'Donnell’s works on UQ eSpace
2015
Conference Publication
Calcium signalling and the acquisition of trastuzumab resistance in HER2 positive breast cancer cells
Kaemmerer, Elke, Pere, Elena, Peters, Amelia A., Yapa, Kunsala T. D. S., Simpson, Fiona, O'Donnell, Jake, Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2015). Calcium signalling and the acquisition of trastuzumab resistance in HER2 positive breast cancer cells. APSA ASCEPT Joint Scientific Meeting 2015, Hobart, TAS Australia, 29 November - 2 December 2015.
Funding
Current funding
Supervision
Availability
- Dr Jake O'Donnell is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Preclinical development and clinical testing of a Human T lymphotropic virus type 1 (HTLV-1)-specific vaccine
Principal Advisor
Other advisors: Professor Keith Chappell, Dr Noushin Jaberolansar
Media
Enquiries
For media enquiries about Dr Jake O'Donnell's areas of expertise, story ideas and help finding experts, contact our Media team: